Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

marketing campaigns

- PMLiVE

Alexion and Aide Health launch app for people with rare diseases

More than 3.5 million people in the UK live with a rare condition

- PMLiVE

Shionogi to acquire IntraBio in deal worth $2bn

The deal will expand Shionogi’s growing portfolio with IntraBio’s rare diseases capabilities

- PMLiVE

ANTHEM launches Healthy Influence – a new science-led approach to solve healthcare’s attention problem

Global healthcare communications consultancy ANTHEM, a Resonant Group company, today announces the launch of Healthy Influence™, its proprietary methodology that applies the science of influence to healthcare communications.

Resonant Group

- PMLiVE

Ogsiveo recommended by NICE to treat rare soft tissue tumours

Desmoid tumours are rare soft tissue tumours that can grow aggressively into nearby tissues

- PMLiVE

The Power of Plurality

A thought piece on plurality of voice, and rewiring the advertising agency of the modern age

11 London

- PMLiVE

Supporting the people who support patients

Supporting those who provide care can lead to improved experiences and health outcomes for everyone involved.

Mednet

- PMLiVE

LEO Pharma acquires rights for dersimelagon from Tanabe Pharma

The company will pay $435m in up front and near-term milestone payments

- PMLiVE

The words around health matter

The language used in healthcare can influence how people perceive their health, feel about themselves, and engage with treatments. Whole-person communication can help reduce stigma and support real-world healthcare outcomes.

Mednet

- PMLiVE

The hidden work of turning breakthroughs into outcomes

The “problem” in healthcare comms is rarely what you say, it’s whether people can act on it. This article explains how we design whole-person engagement to turn intent into sustained...

Mednet

- PMLiVE

LEO Pharma to acquire Replay gene therapy platform

The acquisition will advance innovation for patients with rare skin diseases

- PMLiVE

Shionogi starts phase 2 clinical trial for Pompe Disease

The rare disease affects around one in every 22,000 people worldwide

Pharma website governance

Why pharma website projects stall long before compliance becomes the problem

Pharma teams often blame compliance when digital projects slow down. In reality, the bigger issue is usually weaker ownership, unclear review models and content structures that were never designed for...

Genetic Digital

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links